Literature DB >> 5312524

Comparison of the haemagglutinin production of influenza A2 Hong Kong variant and recombinant strains.

N M Tauraso, T C O'Brien.   

Abstract

Seven Hong Kong variant strains were compared for their capacity to produce haemagglutinin (HA). From the results of 9 serial egg passages made at 33 degrees C and 36 degrees C, the A2/Aichi/2/68 strain was found suitable as the vaccine production strain for the 1968-69 monovalent influenza vaccine manufactured in the United States of America.Results of initial experiments comparing the HA production by 2 Hong Kong variant recombinants and by the A2/Aichi/2/68 strain showed no essential difference among these strains. When these experiments were repeated starting with viruses that had undergone the same number of egg passages from isolation, the mean HA and chicken cell agglutination titres of the 3 recombinant strains used in these studies were only 1.5 times greater than those of the A2/Aichi/2/68 strain. By comparison, the HA producing capacity of A0/PR/8/34 was almost 6 times that of the A2/Aichi/2/68 strain.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5312524      PMCID: PMC2427641     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  GENETIC STUDIES OF INFLUENZA VIRUSES. II. PLAQUE FORMATION BY INFLUENZA VIRUSES IN A CLONE OF A VARIANT HUMAN HETEROPLOID CELL LINE.

Authors:  A SUGIURA; E D KILBOURNE
Journal:  Virology       Date:  1965-07       Impact factor: 3.616

2.  Recombination of influenza A viruses of human and animal origin.

Authors:  E D Kolbourne
Journal:  Science       Date:  1968-04-05       Impact factor: 47.728

3.  The induction of broadened (multitypic) immunity with doubly antigenic influenza virus recombinants.

Authors:  E D Kilbourne; J L Schulman
Journal:  Trans Assoc Am Physicians       Date:  1965

4.  Problems of influenza virus vaccine standardization.

Authors:  N M Tauraso; T C O'Brien; E B Seligman
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

5.  Production and testing in the USA of influenza virus vaccine made from the Hong Kong variant in 1968-69.

Authors:  R Murray
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

6.  QUANTITATIVE ASPECTS OF THE RED BLOOD CELL AGGLUTINATION TEST FOR INFLUENZA VIRUS.

Authors:  G L Miller; W M Stanley
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.